Rheumatoid Arthritis Recruiting Phase 4 Trials for Methotrexate (DB00563)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03737708A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)Treatment
NCT02374021Treatments Against RA and Effect on FDG-PET/CTTreatment
NCT03855007The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months TreatmentTreatment
NCT02837978The Clinical Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months TreatmentTreatment
NCT02874092Ticagrelor in Methotrexate-Resistant Rheumatoid ArthritisTreatment
NCT03505008Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and TaiwanTreatment
NCT02930343Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate MonotherapyTreatment
NCT03254589Methotrexate, Blood Pressure and Arterial Function in Rheumatoid ArthritisTreatment
NCT02764515Kunxian for the Treatment of Rheumatoid ArthritisTreatment
NCT02433184Very Early Versus Delayed Etanercept in Patients With RATreatment